168 related articles for article (PubMed ID: 28834887)
1. C-reactive protein and risk of ovarian cancer: A systematic review and meta-analysis.
Li J; Jiao X; Yuan Z; Qiu H; Guo R
Medicine (Baltimore); 2017 Aug; 96(34):e7822. PubMed ID: 28834887
[TBL] [Abstract][Full Text] [Related]
2. High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium.
Peres LC; Mallen AR; Townsend MK; Poole EM; Trabert B; Allen NE; Arslan AA; Dossus L; Fortner RT; Gram IT; Hartge P; Idahl A; Kaaks R; Kvaskoff M; Magliocco AM; Merritt MA; Quirós JR; Tjonneland A; Trichopoulou A; Tumino R; van Gils CH; Visvanathan K; Wentzensen N; Zeleniuch-Jacquotte A; Tworoger SS
Cancer Res; 2019 Oct; 79(20):5442-5451. PubMed ID: 31462430
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches.
Mun H; Liu B; Pham THA; Wu Q
Osteoporos Int; 2021 Mar; 32(3):425-435. PubMed ID: 32935169
[TBL] [Abstract][Full Text] [Related]
5. Association between C-reactive protein level and subsequent risk of ovarian cancer: A meta-analysis of 13 cohorts in 1,852 ovarian cancer patients.
Wang Y; Zhang Z; Wang J; Zhang X
Medicine (Baltimore); 2020 Jan; 99(5):e18821. PubMed ID: 32000385
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer.
Poole EM; Lee IM; Ridker PM; Buring JE; Hankinson SE; Tworoger SS
Am J Epidemiol; 2013 Oct; 178(8):1256-64. PubMed ID: 23966559
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein and risk of breast cancer: A systematic review and meta-analysis.
Guo L; Liu S; Zhang S; Chen Q; Zhang M; Quan P; Lu J; Sun X
Sci Rep; 2015 May; 5():10508. PubMed ID: 26001129
[TBL] [Abstract][Full Text] [Related]
9. Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study.
Toriola AT; Grankvist K; Agborsangaya CB; Lukanova A; Lehtinen M; Surcel HM
Ann Oncol; 2011 Aug; 22(8):1916-21. PubMed ID: 21292643
[TBL] [Abstract][Full Text] [Related]
10. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis.
Li Y; Zhong X; Cheng G; Zhao C; Zhang L; Hong Y; Wan Q; He R; Wang Z
Atherosclerosis; 2017 Apr; 259():75-82. PubMed ID: 28327451
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and meta-analysis of the effects of soy on serum hs-CRP.
Khodarahmi M; Jafarabadi MA; Moludi J; Abbasalizad Farhangi M
Clin Nutr; 2019 Jun; 38(3):996-1011. PubMed ID: 30314925
[TBL] [Abstract][Full Text] [Related]
12. A Meta-analysis of Randomized Control Trials: The Impact of Vitamin C Supplementation on Serum CRP and Serum hs-CRP Concentrations.
Jafarnejad S; Boccardi V; Hosseini B; Taghizadeh M; Hamedifard Z
Curr Pharm Des; 2018; 24(30):3520-3528. PubMed ID: 30332942
[TBL] [Abstract][Full Text] [Related]
13. Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies.
Guo YZ; Pan L; Du CJ; Ren DQ; Xie XM
Asian Pac J Cancer Prev; 2013; 14(1):243-8. PubMed ID: 23534731
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein and risk of fracture: a systematic review and dose-response meta-analysis of prospective cohort studies.
Wu ZJ; He JL; Wei RQ; Liu B; Lin X; Guan J; Lan YB
Osteoporos Int; 2015 Jan; 26(1):49-57. PubMed ID: 25107320
[TBL] [Abstract][Full Text] [Related]
15. Inflammation markers and risk of developing hypertension: a meta-analysis of cohort studies.
Jayedi A; Rahimi K; Bautista LE; Nazarzadeh M; Zargar MS; Shab-Bidar S
Heart; 2019 May; 105(9):686-692. PubMed ID: 30700522
[TBL] [Abstract][Full Text] [Related]
16. Hs-CRP in stroke: A meta-analysis.
Zhou Y; Han W; Gong D; Man C; Fan Y
Clin Chim Acta; 2016 Jan; 453():21-7. PubMed ID: 26633855
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis.
Zhou L; Cai X; Liu Q; Jian ZY; Li H; Wang KJ
Sci Rep; 2015 Aug; 5():12733. PubMed ID: 26235332
[TBL] [Abstract][Full Text] [Related]
18. The effect of resveratrol supplementation on C-reactive protein (CRP) in type 2 diabetic patients: Results from a systematic review and meta-analysis of randomized controlled trials.
Hosseini H; Koushki M; Khodabandehloo H; Fathi M; Panahi G; Teimouri M; Majidi Z; Meshkani R
Complement Ther Med; 2020 Mar; 49():102251. PubMed ID: 32147058
[TBL] [Abstract][Full Text] [Related]
19. Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome: a meta-analysis: A PRISMA-compliant article.
Wang J; Zhu L; Hu K; Tang Y; Zeng X; Liu J; Xu J
Medicine (Baltimore); 2017 Sep; 96(39):e8183. PubMed ID: 28953677
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of serum C-reactive protein and cartilage oligomeric matrix protein levels as biomarkers for clinical knee osteoarthritis.
Zhang J
BMC Musculoskelet Disord; 2018 Jan; 19(1):22. PubMed ID: 29351749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
